Clearside Biomedical, Inc. - COM (CLSD)

Historical Portfolio Holders from Q2 2016 to Q2 2024

All holders as of June 30, 2024
Q2 2024
Type / Class
Equity / COM
Shares, excl. options Q2 2024
13.8M
Holdings value Q2 2024
$17.9M
Value change Q2 2024
-$2.36M
Grand Portfolio weight change Q2 2024
0%
Number of holders
48
Number of buys Q2 2024
17
Number of sells Q2 2024
-24
Average buys Q2 2024 %
+0%
Average sells Q2 2024 %
0%
Reported Shares, Excluding Options vs Price
Reported Value, Excluding Options
Total Investors
Period Shares, Excl. Options Value, Excl. Options Change Price Investors
2024 Q2 13.8M $17.9M -$2.36M $1.30 48
2024 Q1 15.5M $23.8M +$12M $1.53 53
2023 Q4 7.75M $9.06M +$1.78K $1.17 46
2023 Q3 7.84M $6.82M -$748K $0.87 45
2023 Q2 8.59M $9.62M -$244K $1.12 53
2023 Q1 8.73M $9.08M -$467K $1.04 48
2022 Q4 9.13M $10.2M -$823K $1.12 53
2022 Q3 12.1M $13.6M -$1.86M $1.13 51
2022 Q2 13.7M $20.1M -$4.12M $1.47 50
2022 Q1 16.4M $37.5M -$12.6M $2.29 58
2021 Q4 21M $57.8M -$3.76M $2.75 63
2021 Q3 20.3M $122M +$4.44M $6.00 65
2021 Q2 19.7M $95.8M +$478K $4.87 52
2021 Q1 16.9M $41.8M +$8.59M $2.47 51
2020 Q4 14.3M $39.1M +$4.32M $2.74 40
2020 Q3 12M $18.4M -$35.5K $1.54 41
2020 Q2 11.8M $22.2M +$477K $1.88 44
2020 Q1 11.5M $19.5M +$5.93M $1.70 42
2019 Q4 7.94M $23M +$2.76M $2.90 44
2019 Q3 6.99M $4.4M +$1.25M $0.63 29
2019 Q2 4.51M $4.38M -$1.79M $0.97 42
2019 Q1 6.13M $8.46M -$8.17M $1.38 54
2018 Q4 12.8M $13.7M -$30.8M $1.07 67
2018 Q3 18.5M $114M -$22.9M $6.15 86
2018 Q2 20.4M $218M +$7.95M $10.69 84
2018 Q1 19.6M $211M +$82.1M $10.73 81
2017 Q4 12.3M $86.3M -$5.57M $7.00 52
2017 Q3 13.1M $114M -$1.67M $8.74 49
2017 Q2 13.3M $121M +$12.5M $9.11 51
2017 Q1 12M $95.2M +$3.41M $7.94 57
2016 Q4 11.9M $106M +$35.2M $8.94 60
2016 Q3 7.93M $138M +$10.6M $17.35 30
2016 Q2 7.53M $52.7M +$52.7M $7.01 16